Global Antisense & RNAi Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Antisense & RNAi Therapeutics market size was valued at US$ 937.7 million in 2023. With growing demand in downstream market, the Antisense & RNAi Therapeutics is forecast to a readjusted size of US$ 1268.5 million by 2030 with a CAGR of 4.4% during review period.
The research report highlights the growth potential of the global Antisense & RNAi Therapeutics market. Antisense & RNAi Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antisense & RNAi Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antisense & RNAi Therapeutics market.
Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene 'off'.
North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market.
Key Features:
The report on Antisense & RNAi Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Antisense & RNAi Therapeutics market. It may include historical data, market segmentation by Type (e.g., RNA Interference, SiRNA), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antisense & RNAi Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Antisense & RNAi Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Antisense & RNAi Therapeutics industry. This include advancements in Antisense & RNAi Therapeutics technology, Antisense & RNAi Therapeutics new entrants, Antisense & RNAi Therapeutics new investment, and other innovations that are shaping the future of Antisense & RNAi Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antisense & RNAi Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Antisense & RNAi Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antisense & RNAi Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antisense & RNAi Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antisense & RNAi Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antisense & RNAi Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antisense & RNAi Therapeutics market.
Market Segmentation:
Antisense & RNAi Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Antisense & RNAi Therapeutics market size was valued at US$ 937.7 million in 2023. With growing demand in downstream market, the Antisense & RNAi Therapeutics is forecast to a readjusted size of US$ 1268.5 million by 2030 with a CAGR of 4.4% during review period.
The research report highlights the growth potential of the global Antisense & RNAi Therapeutics market. Antisense & RNAi Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antisense & RNAi Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antisense & RNAi Therapeutics market.
Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene 'off'.
North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market.
Key Features:
The report on Antisense & RNAi Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Antisense & RNAi Therapeutics market. It may include historical data, market segmentation by Type (e.g., RNA Interference, SiRNA), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antisense & RNAi Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Antisense & RNAi Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Antisense & RNAi Therapeutics industry. This include advancements in Antisense & RNAi Therapeutics technology, Antisense & RNAi Therapeutics new entrants, Antisense & RNAi Therapeutics new investment, and other innovations that are shaping the future of Antisense & RNAi Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antisense & RNAi Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Antisense & RNAi Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antisense & RNAi Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antisense & RNAi Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antisense & RNAi Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antisense & RNAi Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antisense & RNAi Therapeutics market.
Market Segmentation:
Antisense & RNAi Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- RNA Interference
- SiRNA
- MiRNA
- Antisense RNA
- Oncology
- Cardiovascular
- Renal
- Neurodegenerative
- Respiratory
- Genetic
- Infectious Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Glaxo Smith Kline
- Sanofi Aventis / Genzyme
- Isis Pharmaceuticals/ Ionis Pharmaceuticals
- Arbutus Biopharma Ltd.
- Silence Therapeutics
- Bio-Path Holdings Inc.
- Calando Pharmaceuticals
- ICo Therapeutics
- Quark Pharmaceuticals
- Rexhan Pharmaceuticals
- Biomarin/Prosensa
- Regulus Therapeutics
- Rxi Pharmaceuticals
- Silenseed
- Dicerna Pharmaceuticals
- Sirnaomics Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antisense & RNAi Therapeutics Market Size 2019-2030
2.1.2 Antisense & RNAi Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Antisense & RNAi Therapeutics Segment by Type
2.2.1 RNA Interference
2.2.2 SiRNA
2.2.3 MiRNA
2.2.4 Antisense RNA
2.3 Antisense & RNAi Therapeutics Market Size by Type
2.3.1 Antisense & RNAi Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Antisense & RNAi Therapeutics Segment by Application
2.4.1 Oncology
2.4.2 Cardiovascular
2.4.3 Renal
2.4.4 Neurodegenerative
2.4.5 Respiratory
2.4.6 Genetic
2.4.7 Infectious Diseases
2.5 Antisense & RNAi Therapeutics Market Size by Application
2.5.1 Antisense & RNAi Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
3 ANTISENSE & RNAI THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Antisense & RNAi Therapeutics Market Size Market Share by Players
3.1.1 Global Antisense & RNAi Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Antisense & RNAi Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTISENSE & RNAI THERAPEUTICS BY REGIONS
4.1 Antisense & RNAi Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Antisense & RNAi Therapeutics Market Size Growth (2019-2024)
4.3 APAC Antisense & RNAi Therapeutics Market Size Growth (2019-2024)
4.4 Europe Antisense & RNAi Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Antisense & RNAi Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Antisense & RNAi Therapeutics Market Size by Country (2019-2024)
5.2 Americas Antisense & RNAi Therapeutics Market Size by Type (2019-2024)
5.3 Americas Antisense & RNAi Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense & RNAi Therapeutics Market Size by Region (2019-2024)
6.2 APAC Antisense & RNAi Therapeutics Market Size by Type (2019-2024)
6.3 APAC Antisense & RNAi Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antisense & RNAi Therapeutics by Country (2019-2024)
7.2 Europe Antisense & RNAi Therapeutics Market Size by Type (2019-2024)
7.3 Europe Antisense & RNAi Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antisense & RNAi Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Antisense & RNAi Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Antisense & RNAi Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET FORECAST
10.1 Global Antisense & RNAi Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Antisense & RNAi Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Antisense & RNAi Therapeutics Forecast
10.1.3 APAC Antisense & RNAi Therapeutics Forecast
10.1.4 Europe Antisense & RNAi Therapeutics Forecast
10.1.5 Middle East & Africa Antisense & RNAi Therapeutics Forecast
10.2 Americas Antisense & RNAi Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Antisense & RNAi Therapeutics Market Forecast
10.2.2 Canada Antisense & RNAi Therapeutics Market Forecast
10.2.3 Mexico Antisense & RNAi Therapeutics Market Forecast
10.2.4 Brazil Antisense & RNAi Therapeutics Market Forecast
10.3 APAC Antisense & RNAi Therapeutics Forecast by Region (2025-2030)
10.3.1 China Antisense & RNAi Therapeutics Market Forecast
10.3.2 Japan Antisense & RNAi Therapeutics Market Forecast
10.3.3 Korea Antisense & RNAi Therapeutics Market Forecast
10.3.4 Southeast Asia Antisense & RNAi Therapeutics Market Forecast
10.3.5 India Antisense & RNAi Therapeutics Market Forecast
10.3.6 Australia Antisense & RNAi Therapeutics Market Forecast
10.4 Europe Antisense & RNAi Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Antisense & RNAi Therapeutics Market Forecast
10.4.2 France Antisense & RNAi Therapeutics Market Forecast
10.4.3 UK Antisense & RNAi Therapeutics Market Forecast
10.4.4 Italy Antisense & RNAi Therapeutics Market Forecast
10.4.5 Russia Antisense & RNAi Therapeutics Market Forecast
10.5 Middle East & Africa Antisense & RNAi Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Antisense & RNAi Therapeutics Market Forecast
10.5.2 South Africa Antisense & RNAi Therapeutics Market Forecast
10.5.3 Israel Antisense & RNAi Therapeutics Market Forecast
10.5.4 Turkey Antisense & RNAi Therapeutics Market Forecast
10.5.5 GCC Countries Antisense & RNAi Therapeutics Market Forecast
10.6 Global Antisense & RNAi Therapeutics Forecast by Type (2025-2030)
10.7 Global Antisense & RNAi Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Glaxo Smith Kline
11.1.1 Glaxo Smith Kline Company Information
11.1.2 Glaxo Smith Kline Antisense & RNAi Therapeutics Product Offered
11.1.3 Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Glaxo Smith Kline Main Business Overview
11.1.5 Glaxo Smith Kline Latest Developments
11.2 Sanofi Aventis / Genzyme
11.2.1 Sanofi Aventis / Genzyme Company Information
11.2.2 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Product Offered
11.2.3 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi Aventis / Genzyme Main Business Overview
11.2.5 Sanofi Aventis / Genzyme Latest Developments
11.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
11.3.1 Isis Pharmaceuticals/ Ionis Pharmaceuticals Company Information
11.3.2 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Isis Pharmaceuticals/ Ionis Pharmaceuticals Main Business Overview
11.3.5 Isis Pharmaceuticals/ Ionis Pharmaceuticals Latest Developments
11.4 Arbutus Biopharma Ltd.
11.4.1 Arbutus Biopharma Ltd. Company Information
11.4.2 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Product Offered
11.4.3 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Arbutus Biopharma Ltd. Main Business Overview
11.4.5 Arbutus Biopharma Ltd. Latest Developments
11.5 Silence Therapeutics
11.5.1 Silence Therapeutics Company Information
11.5.2 Silence Therapeutics Antisense & RNAi Therapeutics Product Offered
11.5.3 Silence Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Silence Therapeutics Main Business Overview
11.5.5 Silence Therapeutics Latest Developments
11.6 Bio-Path Holdings Inc.
11.6.1 Bio-Path Holdings Inc. Company Information
11.6.2 Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Product Offered
11.6.3 Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bio-Path Holdings Inc. Main Business Overview
11.6.5 Bio-Path Holdings Inc. Latest Developments
11.7 Calando Pharmaceuticals
11.7.1 Calando Pharmaceuticals Company Information
11.7.2 Calando Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.7.3 Calando Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Calando Pharmaceuticals Main Business Overview
11.7.5 Calando Pharmaceuticals Latest Developments
11.8 ICo Therapeutics
11.8.1 ICo Therapeutics Company Information
11.8.2 ICo Therapeutics Antisense & RNAi Therapeutics Product Offered
11.8.3 ICo Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ICo Therapeutics Main Business Overview
11.8.5 ICo Therapeutics Latest Developments
11.9 Quark Pharmaceuticals
11.9.1 Quark Pharmaceuticals Company Information
11.9.2 Quark Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.9.3 Quark Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Quark Pharmaceuticals Main Business Overview
11.9.5 Quark Pharmaceuticals Latest Developments
11.10 Rexhan Pharmaceuticals
11.10.1 Rexhan Pharmaceuticals Company Information
11.10.2 Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.10.3 Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Rexhan Pharmaceuticals Main Business Overview
11.10.5 Rexhan Pharmaceuticals Latest Developments
11.11 Biomarin/Prosensa
11.11.1 Biomarin/Prosensa Company Information
11.11.2 Biomarin/Prosensa Antisense & RNAi Therapeutics Product Offered
11.11.3 Biomarin/Prosensa Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Biomarin/Prosensa Main Business Overview
11.11.5 Biomarin/Prosensa Latest Developments
11.12 Regulus Therapeutics
11.12.1 Regulus Therapeutics Company Information
11.12.2 Regulus Therapeutics Antisense & RNAi Therapeutics Product Offered
11.12.3 Regulus Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Regulus Therapeutics Main Business Overview
11.12.5 Regulus Therapeutics Latest Developments
11.13 Rxi Pharmaceuticals
11.13.1 Rxi Pharmaceuticals Company Information
11.13.2 Rxi Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.13.3 Rxi Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Rxi Pharmaceuticals Main Business Overview
11.13.5 Rxi Pharmaceuticals Latest Developments
11.14 Silenseed
11.14.1 Silenseed Company Information
11.14.2 Silenseed Antisense & RNAi Therapeutics Product Offered
11.14.3 Silenseed Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Silenseed Main Business Overview
11.14.5 Silenseed Latest Developments
11.15 Dicerna Pharmaceuticals
11.15.1 Dicerna Pharmaceuticals Company Information
11.15.2 Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.15.3 Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Dicerna Pharmaceuticals Main Business Overview
11.15.5 Dicerna Pharmaceuticals Latest Developments
11.16 Sirnaomics Inc.
11.16.1 Sirnaomics Inc. Company Information
11.16.2 Sirnaomics Inc. Antisense & RNAi Therapeutics Product Offered
11.16.3 Sirnaomics Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Sirnaomics Inc. Main Business Overview
11.16.5 Sirnaomics Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antisense & RNAi Therapeutics Market Size 2019-2030
2.1.2 Antisense & RNAi Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Antisense & RNAi Therapeutics Segment by Type
2.2.1 RNA Interference
2.2.2 SiRNA
2.2.3 MiRNA
2.2.4 Antisense RNA
2.3 Antisense & RNAi Therapeutics Market Size by Type
2.3.1 Antisense & RNAi Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Antisense & RNAi Therapeutics Segment by Application
2.4.1 Oncology
2.4.2 Cardiovascular
2.4.3 Renal
2.4.4 Neurodegenerative
2.4.5 Respiratory
2.4.6 Genetic
2.4.7 Infectious Diseases
2.5 Antisense & RNAi Therapeutics Market Size by Application
2.5.1 Antisense & RNAi Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
3 ANTISENSE & RNAI THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Antisense & RNAi Therapeutics Market Size Market Share by Players
3.1.1 Global Antisense & RNAi Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Antisense & RNAi Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTISENSE & RNAI THERAPEUTICS BY REGIONS
4.1 Antisense & RNAi Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Antisense & RNAi Therapeutics Market Size Growth (2019-2024)
4.3 APAC Antisense & RNAi Therapeutics Market Size Growth (2019-2024)
4.4 Europe Antisense & RNAi Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Antisense & RNAi Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Antisense & RNAi Therapeutics Market Size by Country (2019-2024)
5.2 Americas Antisense & RNAi Therapeutics Market Size by Type (2019-2024)
5.3 Americas Antisense & RNAi Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense & RNAi Therapeutics Market Size by Region (2019-2024)
6.2 APAC Antisense & RNAi Therapeutics Market Size by Type (2019-2024)
6.3 APAC Antisense & RNAi Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antisense & RNAi Therapeutics by Country (2019-2024)
7.2 Europe Antisense & RNAi Therapeutics Market Size by Type (2019-2024)
7.3 Europe Antisense & RNAi Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antisense & RNAi Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Antisense & RNAi Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Antisense & RNAi Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET FORECAST
10.1 Global Antisense & RNAi Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Antisense & RNAi Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Antisense & RNAi Therapeutics Forecast
10.1.3 APAC Antisense & RNAi Therapeutics Forecast
10.1.4 Europe Antisense & RNAi Therapeutics Forecast
10.1.5 Middle East & Africa Antisense & RNAi Therapeutics Forecast
10.2 Americas Antisense & RNAi Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Antisense & RNAi Therapeutics Market Forecast
10.2.2 Canada Antisense & RNAi Therapeutics Market Forecast
10.2.3 Mexico Antisense & RNAi Therapeutics Market Forecast
10.2.4 Brazil Antisense & RNAi Therapeutics Market Forecast
10.3 APAC Antisense & RNAi Therapeutics Forecast by Region (2025-2030)
10.3.1 China Antisense & RNAi Therapeutics Market Forecast
10.3.2 Japan Antisense & RNAi Therapeutics Market Forecast
10.3.3 Korea Antisense & RNAi Therapeutics Market Forecast
10.3.4 Southeast Asia Antisense & RNAi Therapeutics Market Forecast
10.3.5 India Antisense & RNAi Therapeutics Market Forecast
10.3.6 Australia Antisense & RNAi Therapeutics Market Forecast
10.4 Europe Antisense & RNAi Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Antisense & RNAi Therapeutics Market Forecast
10.4.2 France Antisense & RNAi Therapeutics Market Forecast
10.4.3 UK Antisense & RNAi Therapeutics Market Forecast
10.4.4 Italy Antisense & RNAi Therapeutics Market Forecast
10.4.5 Russia Antisense & RNAi Therapeutics Market Forecast
10.5 Middle East & Africa Antisense & RNAi Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Antisense & RNAi Therapeutics Market Forecast
10.5.2 South Africa Antisense & RNAi Therapeutics Market Forecast
10.5.3 Israel Antisense & RNAi Therapeutics Market Forecast
10.5.4 Turkey Antisense & RNAi Therapeutics Market Forecast
10.5.5 GCC Countries Antisense & RNAi Therapeutics Market Forecast
10.6 Global Antisense & RNAi Therapeutics Forecast by Type (2025-2030)
10.7 Global Antisense & RNAi Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Glaxo Smith Kline
11.1.1 Glaxo Smith Kline Company Information
11.1.2 Glaxo Smith Kline Antisense & RNAi Therapeutics Product Offered
11.1.3 Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Glaxo Smith Kline Main Business Overview
11.1.5 Glaxo Smith Kline Latest Developments
11.2 Sanofi Aventis / Genzyme
11.2.1 Sanofi Aventis / Genzyme Company Information
11.2.2 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Product Offered
11.2.3 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi Aventis / Genzyme Main Business Overview
11.2.5 Sanofi Aventis / Genzyme Latest Developments
11.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
11.3.1 Isis Pharmaceuticals/ Ionis Pharmaceuticals Company Information
11.3.2 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Isis Pharmaceuticals/ Ionis Pharmaceuticals Main Business Overview
11.3.5 Isis Pharmaceuticals/ Ionis Pharmaceuticals Latest Developments
11.4 Arbutus Biopharma Ltd.
11.4.1 Arbutus Biopharma Ltd. Company Information
11.4.2 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Product Offered
11.4.3 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Arbutus Biopharma Ltd. Main Business Overview
11.4.5 Arbutus Biopharma Ltd. Latest Developments
11.5 Silence Therapeutics
11.5.1 Silence Therapeutics Company Information
11.5.2 Silence Therapeutics Antisense & RNAi Therapeutics Product Offered
11.5.3 Silence Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Silence Therapeutics Main Business Overview
11.5.5 Silence Therapeutics Latest Developments
11.6 Bio-Path Holdings Inc.
11.6.1 Bio-Path Holdings Inc. Company Information
11.6.2 Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Product Offered
11.6.3 Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bio-Path Holdings Inc. Main Business Overview
11.6.5 Bio-Path Holdings Inc. Latest Developments
11.7 Calando Pharmaceuticals
11.7.1 Calando Pharmaceuticals Company Information
11.7.2 Calando Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.7.3 Calando Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Calando Pharmaceuticals Main Business Overview
11.7.5 Calando Pharmaceuticals Latest Developments
11.8 ICo Therapeutics
11.8.1 ICo Therapeutics Company Information
11.8.2 ICo Therapeutics Antisense & RNAi Therapeutics Product Offered
11.8.3 ICo Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ICo Therapeutics Main Business Overview
11.8.5 ICo Therapeutics Latest Developments
11.9 Quark Pharmaceuticals
11.9.1 Quark Pharmaceuticals Company Information
11.9.2 Quark Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.9.3 Quark Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Quark Pharmaceuticals Main Business Overview
11.9.5 Quark Pharmaceuticals Latest Developments
11.10 Rexhan Pharmaceuticals
11.10.1 Rexhan Pharmaceuticals Company Information
11.10.2 Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.10.3 Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Rexhan Pharmaceuticals Main Business Overview
11.10.5 Rexhan Pharmaceuticals Latest Developments
11.11 Biomarin/Prosensa
11.11.1 Biomarin/Prosensa Company Information
11.11.2 Biomarin/Prosensa Antisense & RNAi Therapeutics Product Offered
11.11.3 Biomarin/Prosensa Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Biomarin/Prosensa Main Business Overview
11.11.5 Biomarin/Prosensa Latest Developments
11.12 Regulus Therapeutics
11.12.1 Regulus Therapeutics Company Information
11.12.2 Regulus Therapeutics Antisense & RNAi Therapeutics Product Offered
11.12.3 Regulus Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Regulus Therapeutics Main Business Overview
11.12.5 Regulus Therapeutics Latest Developments
11.13 Rxi Pharmaceuticals
11.13.1 Rxi Pharmaceuticals Company Information
11.13.2 Rxi Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.13.3 Rxi Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Rxi Pharmaceuticals Main Business Overview
11.13.5 Rxi Pharmaceuticals Latest Developments
11.14 Silenseed
11.14.1 Silenseed Company Information
11.14.2 Silenseed Antisense & RNAi Therapeutics Product Offered
11.14.3 Silenseed Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Silenseed Main Business Overview
11.14.5 Silenseed Latest Developments
11.15 Dicerna Pharmaceuticals
11.15.1 Dicerna Pharmaceuticals Company Information
11.15.2 Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
11.15.3 Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Dicerna Pharmaceuticals Main Business Overview
11.15.5 Dicerna Pharmaceuticals Latest Developments
11.16 Sirnaomics Inc.
11.16.1 Sirnaomics Inc. Company Information
11.16.2 Sirnaomics Inc. Antisense & RNAi Therapeutics Product Offered
11.16.3 Sirnaomics Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Sirnaomics Inc. Main Business Overview
11.16.5 Sirnaomics Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antisense & RNAi Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of RNA Interference
Table 3. Major Players of SiRNA
Table 4. Major Players of MiRNA
Table 5. Major Players of Antisense RNA
Table 6. Antisense & RNAi Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Antisense & RNAi Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Antisense & RNAi Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Antisense & RNAi Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Antisense & RNAi Therapeutics Key Players Head office and Products Offered
Table 15. Antisense & RNAi Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antisense & RNAi Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Antisense & RNAi Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Antisense & RNAi Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Antisense & RNAi Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Antisense & RNAi Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Antisense & RNAi Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Antisense & RNAi Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Antisense & RNAi Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Antisense & RNAi Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Antisense & RNAi Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Antisense & RNAi Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Antisense & RNAi Therapeutics
Table 47. Key Market Challenges & Risks of Antisense & RNAi Therapeutics
Table 48. Key Industry Trends of Antisense & RNAi Therapeutics
Table 49. Global Antisense & RNAi Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Antisense & RNAi Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Antisense & RNAi Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Antisense & RNAi Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Glaxo Smith Kline Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 54. Glaxo Smith Kline Antisense & RNAi Therapeutics Product Offered
Table 55. Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Glaxo Smith Kline Main Business
Table 57. Glaxo Smith Kline Latest Developments
Table 58. Sanofi Aventis / Genzyme Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 59. Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Product Offered
Table 60. Sanofi Aventis / Genzyme Main Business
Table 61. Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Sanofi Aventis / Genzyme Latest Developments
Table 63. Isis Pharmaceuticals/ Ionis Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 64. Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 65. Isis Pharmaceuticals/ Ionis Pharmaceuticals Main Business
Table 66. Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Isis Pharmaceuticals/ Ionis Pharmaceuticals Latest Developments
Table 68. Arbutus Biopharma Ltd. Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 69. Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Product Offered
Table 70. Arbutus Biopharma Ltd. Main Business
Table 71. Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Arbutus Biopharma Ltd. Latest Developments
Table 73. Silence Therapeutics Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 74. Silence Therapeutics Antisense & RNAi Therapeutics Product Offered
Table 75. Silence Therapeutics Main Business
Table 76. Silence Therapeutics Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Silence Therapeutics Latest Developments
Table 78. Bio-Path Holdings Inc. Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 79. Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Product Offered
Table 80. Bio-Path Holdings Inc. Main Business
Table 81. Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Bio-Path Holdings Inc. Latest Developments
Table 83. Calando Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 84. Calando Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 85. Calando Pharmaceuticals Main Business
Table 86. Calando Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Calando Pharmaceuticals Latest Developments
Table 88. ICo Therapeutics Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 89. ICo Therapeutics Antisense & RNAi Therapeutics Product Offered
Table 90. ICo Therapeutics Main Business
Table 91. ICo Therapeutics Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. ICo Therapeutics Latest Developments
Table 93. Quark Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 94. Quark Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 95. Quark Pharmaceuticals Main Business
Table 96. Quark Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Quark Pharmaceuticals Latest Developments
Table 98. Rexhan Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 99. Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 100. Rexhan Pharmaceuticals Main Business
Table 101. Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Rexhan Pharmaceuticals Latest Developments
Table 103. Biomarin/Prosensa Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 104. Biomarin/Prosensa Antisense & RNAi Therapeutics Product Offered
Table 105. Biomarin/Prosensa Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Biomarin/Prosensa Main Business
Table 107. Biomarin/Prosensa Latest Developments
Table 108. Regulus Therapeutics Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 109. Regulus Therapeutics Antisense & RNAi Therapeutics Product Offered
Table 110. Regulus Therapeutics Main Business
Table 111. Regulus Therapeutics Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Regulus Therapeutics Latest Developments
Table 113. Rxi Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 114. Rxi Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 115. Rxi Pharmaceuticals Main Business
Table 116. Rxi Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Rxi Pharmaceuticals Latest Developments
Table 118. Silenseed Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 119. Silenseed Antisense & RNAi Therapeutics Product Offered
Table 120. Silenseed Main Business
Table 121. Silenseed Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Silenseed Latest Developments
Table 123. Dicerna Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 124. Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 125. Dicerna Pharmaceuticals Main Business
Table 126. Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Dicerna Pharmaceuticals Latest Developments
Table 128. Sirnaomics Inc. Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 129. Sirnaomics Inc. Antisense & RNAi Therapeutics Product Offered
Table 130. Sirnaomics Inc. Main Business
Table 131. Sirnaomics Inc. Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Sirnaomics Inc. Latest Developments
Table 1. Antisense & RNAi Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of RNA Interference
Table 3. Major Players of SiRNA
Table 4. Major Players of MiRNA
Table 5. Major Players of Antisense RNA
Table 6. Antisense & RNAi Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Antisense & RNAi Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Antisense & RNAi Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Antisense & RNAi Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Antisense & RNAi Therapeutics Key Players Head office and Products Offered
Table 15. Antisense & RNAi Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antisense & RNAi Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Antisense & RNAi Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Antisense & RNAi Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Antisense & RNAi Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Antisense & RNAi Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Antisense & RNAi Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Antisense & RNAi Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Antisense & RNAi Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Antisense & RNAi Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Antisense & RNAi Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Antisense & RNAi Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Antisense & RNAi Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Antisense & RNAi Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Antisense & RNAi Therapeutics
Table 47. Key Market Challenges & Risks of Antisense & RNAi Therapeutics
Table 48. Key Industry Trends of Antisense & RNAi Therapeutics
Table 49. Global Antisense & RNAi Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Antisense & RNAi Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Antisense & RNAi Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Antisense & RNAi Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Glaxo Smith Kline Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 54. Glaxo Smith Kline Antisense & RNAi Therapeutics Product Offered
Table 55. Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Glaxo Smith Kline Main Business
Table 57. Glaxo Smith Kline Latest Developments
Table 58. Sanofi Aventis / Genzyme Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 59. Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Product Offered
Table 60. Sanofi Aventis / Genzyme Main Business
Table 61. Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Sanofi Aventis / Genzyme Latest Developments
Table 63. Isis Pharmaceuticals/ Ionis Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 64. Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 65. Isis Pharmaceuticals/ Ionis Pharmaceuticals Main Business
Table 66. Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Isis Pharmaceuticals/ Ionis Pharmaceuticals Latest Developments
Table 68. Arbutus Biopharma Ltd. Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 69. Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Product Offered
Table 70. Arbutus Biopharma Ltd. Main Business
Table 71. Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Arbutus Biopharma Ltd. Latest Developments
Table 73. Silence Therapeutics Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 74. Silence Therapeutics Antisense & RNAi Therapeutics Product Offered
Table 75. Silence Therapeutics Main Business
Table 76. Silence Therapeutics Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Silence Therapeutics Latest Developments
Table 78. Bio-Path Holdings Inc. Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 79. Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Product Offered
Table 80. Bio-Path Holdings Inc. Main Business
Table 81. Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Bio-Path Holdings Inc. Latest Developments
Table 83. Calando Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 84. Calando Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 85. Calando Pharmaceuticals Main Business
Table 86. Calando Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Calando Pharmaceuticals Latest Developments
Table 88. ICo Therapeutics Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 89. ICo Therapeutics Antisense & RNAi Therapeutics Product Offered
Table 90. ICo Therapeutics Main Business
Table 91. ICo Therapeutics Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. ICo Therapeutics Latest Developments
Table 93. Quark Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 94. Quark Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 95. Quark Pharmaceuticals Main Business
Table 96. Quark Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Quark Pharmaceuticals Latest Developments
Table 98. Rexhan Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 99. Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 100. Rexhan Pharmaceuticals Main Business
Table 101. Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Rexhan Pharmaceuticals Latest Developments
Table 103. Biomarin/Prosensa Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 104. Biomarin/Prosensa Antisense & RNAi Therapeutics Product Offered
Table 105. Biomarin/Prosensa Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Biomarin/Prosensa Main Business
Table 107. Biomarin/Prosensa Latest Developments
Table 108. Regulus Therapeutics Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 109. Regulus Therapeutics Antisense & RNAi Therapeutics Product Offered
Table 110. Regulus Therapeutics Main Business
Table 111. Regulus Therapeutics Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Regulus Therapeutics Latest Developments
Table 113. Rxi Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 114. Rxi Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 115. Rxi Pharmaceuticals Main Business
Table 116. Rxi Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Rxi Pharmaceuticals Latest Developments
Table 118. Silenseed Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 119. Silenseed Antisense & RNAi Therapeutics Product Offered
Table 120. Silenseed Main Business
Table 121. Silenseed Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Silenseed Latest Developments
Table 123. Dicerna Pharmaceuticals Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 124. Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Product Offered
Table 125. Dicerna Pharmaceuticals Main Business
Table 126. Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Dicerna Pharmaceuticals Latest Developments
Table 128. Sirnaomics Inc. Details, Company Type, Antisense & RNAi Therapeutics Area Served and Its Competitors
Table 129. Sirnaomics Inc. Antisense & RNAi Therapeutics Product Offered
Table 130. Sirnaomics Inc. Main Business
Table 131. Sirnaomics Inc. Antisense & RNAi Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Sirnaomics Inc. Latest Developments
LIST OF FIGURES
Figure 1. Antisense & RNAi Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antisense & RNAi Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Antisense & RNAi Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Antisense & RNAi Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Antisense & RNAi Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Antisense & RNAi Therapeutics Market Size Market Share by Type in 2023
Figure 10. Antisense & RNAi Therapeutics in Oncology
Figure 11. Global Antisense & RNAi Therapeutics Market: Oncology (2019-2024) & ($ Millions)
Figure 12. Antisense & RNAi Therapeutics in Cardiovascular
Figure 13. Global Antisense & RNAi Therapeutics Market: Cardiovascular (2019-2024) & ($ Millions)
Figure 14. Antisense & RNAi Therapeutics in Renal
Figure 15. Global Antisense & RNAi Therapeutics Market: Renal (2019-2024) & ($ Millions)
Figure 16. Antisense & RNAi Therapeutics in Neurodegenerative
Figure 17. Global Antisense & RNAi Therapeutics Market: Neurodegenerative (2019-2024) & ($ Millions)
Figure 18. Antisense & RNAi Therapeutics in Respiratory
Figure 19. Global Antisense & RNAi Therapeutics Market: Respiratory (2019-2024) & ($ Millions)
Figure 20. Antisense & RNAi Therapeutics in Genetic
Figure 21. Global Antisense & RNAi Therapeutics Market: Genetic (2019-2024) & ($ Millions)
Figure 22. Antisense & RNAi Therapeutics in Infectious Diseases
Figure 23. Global Antisense & RNAi Therapeutics Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 24. Global Antisense & RNAi Therapeutics Market Size Market Share by Application in 2023
Figure 25. Global Antisense & RNAi Therapeutics Revenue Market Share by Player in 2023
Figure 26. Global Antisense & RNAi Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 27. Americas Antisense & RNAi Therapeutics Market Size 2019-2024 ($ Millions)
Figure 28. APAC Antisense & RNAi Therapeutics Market Size 2019-2024 ($ Millions)
Figure 29. Europe Antisense & RNAi Therapeutics Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa Antisense & RNAi Therapeutics Market Size 2019-2024 ($ Millions)
Figure 31. Americas Antisense & RNAi Therapeutics Value Market Share by Country in 2023
Figure 32. United States Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC Antisense & RNAi Therapeutics Market Size Market Share by Region in 2023
Figure 37. APAC Antisense & RNAi Therapeutics Market Size Market Share by Type in 2023
Figure 38. APAC Antisense & RNAi Therapeutics Market Size Market Share by Application in 2023
Figure 39. China Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. India Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe Antisense & RNAi Therapeutics Market Size Market Share by Country in 2023
Figure 46. Europe Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Europe Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Germany Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. France Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Figure 56. Egypt Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. APAC Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Europe Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. United States Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Canada Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Mexico Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Brazil Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. China Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Japan Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Korea Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. India Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Australia Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Germany Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. France Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. UK Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Italy Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Russia Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Spain Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. Egypt Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. South Africa Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 83. Israel Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 84. Turkey Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 86. Global Antisense & RNAi Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global Antisense & RNAi Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Antisense & RNAi Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antisense & RNAi Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Antisense & RNAi Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Antisense & RNAi Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Antisense & RNAi Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Antisense & RNAi Therapeutics Market Size Market Share by Type in 2023
Figure 10. Antisense & RNAi Therapeutics in Oncology
Figure 11. Global Antisense & RNAi Therapeutics Market: Oncology (2019-2024) & ($ Millions)
Figure 12. Antisense & RNAi Therapeutics in Cardiovascular
Figure 13. Global Antisense & RNAi Therapeutics Market: Cardiovascular (2019-2024) & ($ Millions)
Figure 14. Antisense & RNAi Therapeutics in Renal
Figure 15. Global Antisense & RNAi Therapeutics Market: Renal (2019-2024) & ($ Millions)
Figure 16. Antisense & RNAi Therapeutics in Neurodegenerative
Figure 17. Global Antisense & RNAi Therapeutics Market: Neurodegenerative (2019-2024) & ($ Millions)
Figure 18. Antisense & RNAi Therapeutics in Respiratory
Figure 19. Global Antisense & RNAi Therapeutics Market: Respiratory (2019-2024) & ($ Millions)
Figure 20. Antisense & RNAi Therapeutics in Genetic
Figure 21. Global Antisense & RNAi Therapeutics Market: Genetic (2019-2024) & ($ Millions)
Figure 22. Antisense & RNAi Therapeutics in Infectious Diseases
Figure 23. Global Antisense & RNAi Therapeutics Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 24. Global Antisense & RNAi Therapeutics Market Size Market Share by Application in 2023
Figure 25. Global Antisense & RNAi Therapeutics Revenue Market Share by Player in 2023
Figure 26. Global Antisense & RNAi Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 27. Americas Antisense & RNAi Therapeutics Market Size 2019-2024 ($ Millions)
Figure 28. APAC Antisense & RNAi Therapeutics Market Size 2019-2024 ($ Millions)
Figure 29. Europe Antisense & RNAi Therapeutics Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa Antisense & RNAi Therapeutics Market Size 2019-2024 ($ Millions)
Figure 31. Americas Antisense & RNAi Therapeutics Value Market Share by Country in 2023
Figure 32. United States Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC Antisense & RNAi Therapeutics Market Size Market Share by Region in 2023
Figure 37. APAC Antisense & RNAi Therapeutics Market Size Market Share by Type in 2023
Figure 38. APAC Antisense & RNAi Therapeutics Market Size Market Share by Application in 2023
Figure 39. China Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. India Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe Antisense & RNAi Therapeutics Market Size Market Share by Country in 2023
Figure 46. Europe Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Europe Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Germany Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. France Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa Antisense & RNAi Therapeutics Market Size Market Share by Application (2019-2024)
Figure 56. Egypt Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country Antisense & RNAi Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. APAC Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Europe Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. United States Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Canada Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Mexico Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Brazil Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. China Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Japan Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Korea Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. India Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Australia Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Germany Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. France Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. UK Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Italy Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Russia Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Spain Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. Egypt Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. South Africa Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 83. Israel Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 84. Turkey Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries Antisense & RNAi Therapeutics Market Size 2025-2030 ($ Millions)
Figure 86. Global Antisense & RNAi Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global Antisense & RNAi Therapeutics Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Bone Fixation Devices Market Growth 2023-2029
US$ 3,660.00
March 2023
128 pages
Global Inflatable Pessaries Market Growth 2024-2030
US$ 3,660.00
March 2024
113 pages
Global Material Transfer System Market Growth 2023-2029
US$ 3,660.00
January 2023
117 pages
Global Microvascular Anastomosis Market Growth 2025-2031
US$ 3,660.00
April 2025
77 pages
